Table 1.
The experimental results of IL-6, cTnI, and NT-proBNP in subject serums. It should be noted that the measurement units of ELISA have been transferred to molar concentration.
| Sub. No. | ELISA (pM) | CMOS Biosensor (NDR) | Note (Symptoms) | ||||
|---|---|---|---|---|---|---|---|
| IL-6 | cTnI | NT-proBNP | IL-6 | cTnI | NT-proBNP | ||
| 1 | 4 ± 1.8 | 0 ± 0.0 | 2 ± 1.0 | 0.005 ± 0.001 | 0.011 ± 0.009 | 0.003 ± 0.001 | Healthy people |
| 2 | 654 ± 3.8 | - | - | 0.019 ± 0.007 | - | - | coronary artery disease |
| 3 | 5855 ± 5.9 | - | - | 0.076 ± 0.034 | - | - | |
| 4 | - | 368 ± 0.6 | - | - | 0.111 ± 0.022 | - | myocardial infarction |
| 5 | - | 494 ± 1.1 | - | - | 0.148 ± 0.041 | - | |
| 6 | - | - | 463 ± 0.2 | - | - | 0.049 ± 0.034 | congestive heart failure |
| 7 | - | - | 8960 ± 24.4 | - | - | 0.192 ± 0.023 | |
| 8 | 4654 ± 5.9 | 630 ± 6.4 | 5940 ± 24.6 | 0.056 ± 0.022 | 0.186 ± 0.036 | 0.108 ± 0.057 | coronary artery disease & congestive heart failure & myocardial infarction |